| Name: | (2R,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one; [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a] |
| Synonyms: | AC1L4EHM;(2R,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one; [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] acetate; [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] hexanoate; [(2R,5S,8R,9S,10S,13S,14S,17S)-2,10,13-trimethyl-3-oxo-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] propanoate;70003-55-3;Androstan-3-one, 17-(acetyloxy)-2-methyl-, (2alpha,5alpha,17beta)-,mixt. with (2alpha,5alpha,17beta)-17-hydroxy-2-methylandrostan-3-one, (2alpha,5alpha,17beta)-2-methyl-17-((1-oxohexyl)oxy)androstan-3-one and (2alpha,5alpha,17beta)-2-methyl-17-(1-oxopropoxy)androstan-3-one |
| InChI: | InChI=1/C26H42O3.C23H36O3.C22H34O3.C20H32O2/c1-5-6-7-8-24(28)29-23-12-11-20-19-10-9-18-15-22(27)17(2)16-26(18,4)21(19)13-14-25(20,23)3;1-5-21(25)26-20-9-8-17-16-7-6-15-12-19(24)14(2)13-23(15,4)18(16)10-11-22(17,20)3;1-13-12-22(4)15(11-19(13)24)5-6-16-17-7-8-20(25-14(2)23)21(17,3)10-9-18(16)22;1-12-11-20(3)13(10-17(12)21)4-5-14-15-6-7-18(22)19(15,2)9-8-16(14)20/h17-21,23H,5-16H2,1-4H3;14-18,20H,5-13H2,1-4H3;13,15-18,20H,5-12H2,1-4H3;12-16,18,22H,4-11H2,1-3H3/t17-,18+,19+,20+,21+,23+,25+,26+;14-,15+,16+,17+,18+,20+,22+,23+;13-,15+,16+,17+,18+,20+,21+,22+;12-,13+,14+,15+,16+,18+,19+,20+/m1111/s1 |
